1
|
Perri D, Mazzoleni F, Besana U, Pacchetti A, Morini E, Calandriello M, Pastore AL, Romero-Otero J, Bruyere F, Sighinolfi MC, Rocco B, Micali S, Gozen AS, Liatsikos E, Roche JB, Bozzini G. A proposed mathematical model to help preoperative planning between RIRS and MiniPerc for renal stones between 10 and 20 mm using holmium:Yag laser (Cyber Ho): the stone management according to size-hardness (SMASH) score. Urolithiasis 2024; 52:58. [PMID: 38565776 DOI: 10.1007/s00240-024-01536-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2023] [Accepted: 01/22/2024] [Indexed: 04/04/2024]
Abstract
To evaluate the performance of a mathematical model to drive preoperative planning between RIRS and MiniPerc (MP) for the treatment of renal stones between 10 and 20 mm. Patients with a renal stone between 10 and 20 mm were enrolled. A mathematical model named Stone Management According to Size-Hardness (SMASH) score was calculated: hounsfield units (HU) χ stone maximum size (cm)/100. Patients were divided into 4 groups: RIRS with score < 15 (Group A), RIRS with score ≥ 15 (Group B), MP with score < 15 (Group C), MP with score ≥ 15 (Group D). Cyber Ho device was always used. Stone free rate (SFR) was assessed after 3 months. Complication rate and need for auxiliary procedures were evaluated. Between January 2019 and December 2021, 350 patients were enrolled (87, 88, 82 and 93 in Groups A, B, C and D). Mean stone size was 13.1 vs 13.3 mm in Group A vs B (p = 0.18) and 16.2 vs 18.1 mm in Group C vs D (p = 0.12). SFR was 82%, 61%, 75% and 85% for Groups A, B, C and D. SFR was comparable between Groups C and D (p = 0.32) and Groups A and C (p = 0.22). SFR was significantly higher in Group A over B (p = 0.03) and in Group D over B (p = 0.02). Complication rate was 2.2%, 3.4%, 12.1%, 12.9% for Groups A, B, C, D. RIRS and MP are both safe and effective. The mathematical model with the proposed cut-off allowed a proper allocation of patients between endoscopic and percutaneous approaches.Registration number of the study ISRCTN55546280.
Collapse
Affiliation(s)
- D Perri
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy.
- Department of Urology, Sant'Anna Hospital, Via Ravona 20, 22042, San Fermo della Battaglia, Italy.
| | - F Mazzoleni
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| | - U Besana
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| | - A Pacchetti
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| | - E Morini
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| | - M Calandriello
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| | - A L Pastore
- Department of Urology, Sapienza University, Rome, Italy
| | - J Romero-Otero
- Department of Urology, Hospital Universitario, 12 De Octubre, Madrid, Spain
| | - F Bruyere
- Department of Urology, Bretonneau Hospital, Tours, France
| | | | - B Rocco
- Department of Urology, Ospedale San Paolo, Milan, Italy
| | - S Micali
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - A S Gozen
- Department of Urology, SLK-Kliniken Heilbronn, Heilbronn, Germany
| | - E Liatsikos
- Department of Urology, University of Patras, Patras, Greece
| | - J B Roche
- Department of Urology, University of Bordeaux, Bordeaux, France
| | - G Bozzini
- Department of Urology, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy
| |
Collapse
|
2
|
Perri D, Mazzoleni F, Besana U, Pacchetti A, Morini E, Berti L, Calandriello M, Pastore AL, Romero-Otero J, Bruyere F, Sighinolfi MC, Rocco B, Micali S, Gozen AS, Liatsikos E, Roche JB, Bozzini G. Pulsed-wave vs Continuous-wave Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): A Comparison of Perioperative Outcomes. Urology 2023; 178:120-124. [PMID: 37257589 DOI: 10.1016/j.urology.2023.05.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2022] [Revised: 04/07/2023] [Accepted: 05/16/2023] [Indexed: 06/02/2023]
Abstract
OBJECTIVE To compare intra and early postoperative outcomes between pulsed-wave and continuous-wave Thulium Fiber Laser Enucleation of the Prostate (PW-ThuFLEP vs CW-ThuFLEP) for the treatment of benign prostatic hyperplasia. METHODS 238 patients with lower urinary tract symptoms due to benign prostatic hyperplasia underwent PW-ThuFLEP (118 patients) vs CW-ThuFLEP (120 patients). Preoperative prostate volume, adenoma volume, prostate-specific antigen (PSA), and hemoglobin values were recorded. International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), post-void residual volume, and International Index of Erectile Function-5 score (IIEF-5) were assessed. Operative time, enucleation time, enucleation efficiency, catheterization time, irrigation volume, hospital stay, hemoglobin drop, and postoperative complications were recorded. Micturition improvements and sexual outcomes were evaluated 3months after surgery. RESULTS CW-ThuFLEP showed shorter operative time (61.5 vs 67.4 minutes, P = .04). Enucleation time (50.2 vs 53.3 minutes, P = .12), enucleation efficiency (0.8 vs 0.7 g/min, P = .38), catheterization time (2.2 vs 2.1days, P = .29), irrigation volume (32.9 vs 32.8L, P = .71), hospital stay (2.8 vs 2.6days, P = .29) and hemoglobin drop (0.38 vs 0.39 g/dL, P = .53) were comparable. No significant difference in complication rate was observed. At 3-month follow-up, the procedures did not show any significant difference in IPSS, Qmax, post-void residual volume, IIEF-5, and PSA value. CONCLUSION PW-ThuFLEP and CW-ThuFLEP both relieve lower urinary tract symptoms equally, with high efficacy and safety. Operative time was significantly shorter with CW-ThuFLEP, but with a small difference with low clinical impact. Enucleation time, enucleation efficiency, catheterization time, irrigation volume, hospital stay, hemoglobin and PSA drop, complication rate, and sexual outcomes showed no differences.
Collapse
Affiliation(s)
- D Perri
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy.
| | - F Mazzoleni
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| | - U Besana
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| | - A Pacchetti
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| | - E Morini
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| | - L Berti
- Department of Urology, ASST Valle Olona, Busto Arsizio Hospital, Busto Arsizio, Italy
| | - M Calandriello
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| | - A L Pastore
- Department of Urology, Sapienza University of Rome, Latina, Italy
| | - J Romero-Otero
- Department of Urology, Hospital Universitario HM Montepríncipe, Madrid, Spain
| | - F Bruyere
- Department of Urology, CHRU Bretonneau, Tours, France
| | - M C Sighinolfi
- Department of Urology, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy
| | - B Rocco
- Department of Urology, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy
| | - S Micali
- Department of Urology, Modena and Reggio Emilia University, Modena, Italy
| | - A S Gozen
- Department of Urology, SLK-Kliniken, University of Heidelberg, Heilbronn, Germany
| | - E Liatsikos
- Department of Urology, University of Patras, Patras, Greece
| | - J B Roche
- Department of Urology, Clinique Saint Augustin, Bordeaux, France
| | - G Bozzini
- Department of Urology, Sant'Anna Hospital, San Fermo della Battaglia, Italy
| |
Collapse
|
3
|
Girard C, El-Akri M, Durand M, Guérin O, Rambaud C, Cornu J, Brierre T, Cousin T, Gaillard V, Tricard T, Dupuis H, Hermieu N, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu J, Lecoanet P, Capon G, Game X, Saussine C, Peyronnet B, Bentellis I. Efficacy, safety and reoperation-free survival of artificial urinary sphincter in non neurological male patients over 75 years of age. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00819-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
4
|
Proye P, Gondran-Tellier B, Baboudjian M, Bernhard J, Bensalah K, Bigot P, Mejean A, Doumerc N, Ingels A, Paparel P, Bruyere F, Vaessen C, Olivier J, Nouhaud F, Lebacle C, Tillou X, Durand X, Pignot G, Boissier R. Diagnostic performance of tumor biopsy for the diagnosis of renal tumors in the UroCCR network. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01316-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Klein C, Bensalah K, Champy C, Bensalah K, Champy C, Olivier J, Doumerc N, Audenet F, Branger N, Roupret M, Surlemont L, Bruyere F, Durand X, Parier B, Durand M, Waeckel T, Rouget B, Gaillard V, Xylinas E, Vallee M, Long J, Bernhard J. Does Simplified PADUA Renal (SPARE) Nephrometry scoring system can help predicting renal function outcomes after Robot-Assisted Partial Nephrectomy (RAPN) (UroCCR study 93)? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00904-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Proye P, Gondran-Tellier B, Baboudjian M, Bernhard J, Bensalah K, Bigot P, Mejean A, Doumerc N, Ingels A, Paparel P, Bruyere F, Vaessen C, Olivier J, Nouhaud F, Lebacle C, Tillou X, Durand X, Pignot G, Boissier R. Practice and impact of tumor biopsy on the management of kidney tumors in the UroCCR registry (Ancillary Study n°118). Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01317-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
7
|
Bruyere F, Grammatico-Guillon L, De Lafforest S. Characteristics of women with acute pyelonephritis in a historic five-year cohort and predictors of ultrasound abnormalities among women treated for acute pyelonephritis in outpatient care: a prospective study. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)00776-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
El Akri M, Bentellis I, Tricard T, Brierre T, Cousin T, Dupuis H, Hermieu N, Gaillard V, Poussot B, Robin D, Pitout A, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Saussine C, Hermieu J, Lecoanet P, Capon G, Cornu JN, Game X, Ruffion A, Peyronnet B. Transcorporal vs. bulbar artificial urinary sphincter implantation in male patients with fragile urethra. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00664-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Robin D, Peyronnet B, Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Poussot B, Dupuis H, Tricard T, Hermieu N, Pitout A, Beraud F, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Hermieu JF, Lecoanet P, Capon G, Saussine C, Gamé X, Léon P. Sphincter urinaire artificiel chez les patients présentant une incontinence urinaire après High Intensivity Focused Ultrasound Therapy. Prog Urol 2022; 32:284-290. [DOI: 10.1016/j.purol.2021.11.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 11/14/2021] [Accepted: 11/15/2021] [Indexed: 10/19/2022]
|
10
|
Bruyere F, Guillon L, Gaborit C, Vallé-e M, Ruimy J, Sotto A, Conan Y. Facteurs prédictifs de gravité d’une pyélonéphrite aiguë sur une cohorte de 2401 femmes. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
11
|
Surlemont L, Bernarhd J, Bensalah K, Bigot P, Doumerc N, De la taille A, Rouprêt M, Villers A, Bruyere F, Lebacle C, Lang H, Durand X, Tillou X, Long J, Rouget B, Durand M, Pignot G, Larre S, Cussenot O, Nouhaud F. Impact de l’obésité dans la prise en charge du cancer du rein, étude URO-CCR N°87. Prog Urol 2021. [DOI: 10.1016/j.purol.2021.08.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Seizilles de Mazancourt E, Vallée M, Sotto A, Le Goux C, Dihn A, Therby A, Boissier R, Savoie PH, Long JA, Bruyere F. [Infectious emergencies in urology]. Prog Urol 2021; 31:978-986. [PMID: 34420878 DOI: 10.1016/j.purol.2021.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 07/20/2021] [Indexed: 11/18/2022]
Abstract
OBJECTIVE To report the nature, diagnosis and therapeutic strategy of infectious emergencies in urology. MATERIAL AND METHODS Bibliographic research from Pubmed, Embase, and Google scholar in July 2021. A synthesis of the guidelines of national infectious diseases societies. RESULTS Urosepsis and complicated urinary tract infection have a standardized definition. Diagnosis and therapeutic strategy are presented for upper tract urinary infection, male urinary infection, healthcare associated urinary infection, symptomatic canduria and urinary infections of the elderly. Appropriate antibiotherapy should be tailored to the degree of severity, bacterial ecosystem, patient characteristics et localization of the infection. CONCLUSION Urinary infections can be critical and require immediate care. Knowledge of the guidelines and of appropriate diagnosis and therapeutics strategy improve care which should be rapidly applied, and collegial.
Collapse
Affiliation(s)
- E Seizilles de Mazancourt
- Service d'urologie et de la transplantation, Hôpital Édouard-Herriot, hospices civils de Lyon, 69008 Lyon, France
| | - M Vallée
- Service d'urologie, CHRU Poitiers, 86000 Poitiers, France
| | - A Sotto
- Service de maladies infectieuses, CHU Nîmes, 30000 Nîmes, France
| | - C Le Goux
- Centre Alfred-Kastler, Hôpital privé Nord parisien, 95200 Sarcelles, France
| | - A Dihn
- Service de maladies infectieuses, CHU Garches, 92380 France
| | - A Therby
- Service de maladies infectieuses, CH Versailles, 78150 France
| | - R Boissier
- Hopital de la conception, Assistance publique Hôpitaux de Marseille, 13005, France
| | - P H Savoie
- Hôpital d'Instruction des Armées Saint-Anne, BP 600, 83190 Toulon cedex 09
| | - J A Long
- Service d'urologie, Centre hospitalier universitaire de Grenoble, 38000 France; TIMC-IMAG, CNRS 5525, France
| | - F Bruyere
- Service d'urologie, CHRU Tours, 2, boulevard Tonnellé, 37044 Tours cedex, France.
| |
Collapse
|
13
|
de Lafforest S, Magnier A, Vallée M, Le Goux C, Zahar J, Sotto A, Bruyere F, Grammatico-Guillon L. Incidence des infections urinaires hospitalisées en France : une cohorte historique. Infect Dis Now 2021. [DOI: 10.1016/j.idnow.2021.06.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
14
|
de Lafforest S, Magnier A, Vallée M, Bey E, Le Goux C, Saint F, Therby A, Zahar JR, Sotto A, Bruyere F, Grammatico-Guillon L. FUrTIHF: French urinary tract infections in healthcare facilities - five-year historic cohort (2014-2018). J Hosp Infect 2021; 116:29-36. [PMID: 34166732 DOI: 10.1016/j.jhin.2021.04.035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 04/19/2021] [Accepted: 04/19/2021] [Indexed: 11/29/2022]
Abstract
BACKGROUND Urinary tract infections (UTIs) are common and diverse. Even when not severe, UTIs regularly lead to hospitalization, but their hospital burden remains unknown. This study aimed to estimate the national incidence of hospitalized UTIs in France. METHODS A historic five-year cohort of adult patients hospitalized with UTIs in France was extracted from the medico-administrative databases using an ICD-10 code algorithm built by a multidisciplinary team. The performance parameters were estimated blindly, by reviewing 1122 cases, using medical reports as the gold standard, giving a global predictive positive value of 70.4% (95% confidence interval 66.6-74.1). The national incidence of UTIs was then estimated. RESULTS A total of 2,083,973 patients with UTIs were hospitalized over the period, giving an adjusted incidence rate of ∼900 cases/100,000 inhabitants, stable over the period, higher in females and increasing with age; 1.2% were device-associated UTIs. Unspecific acute cystitis represented almost two-thirds of cases (63.5%); followed by pyelonephritis (23.6%) and prostatitis (12.4%). More than three-quarters of patients had at least one comorbid condition (76.8%). CONCLUSIONS This national cohort study is the first to date to estimate the incidence of UTI-related hospitalizations in France. UTIs represent a substantial burden of care. Further analysis will provide data for more informed goal-of-care discussions targeting each type of UTI, their management and outcomes.
Collapse
Affiliation(s)
- S de Lafforest
- EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; Equipe EA 7505 Education éthique santé, Université de Tours, France
| | - A Magnier
- CHU d'Angers, service d'urologie, Université Angers, France; Service d'urologie, CHRU de Tours, France
| | - M Vallée
- Department of Urology, Poitiers University Hospital, Université de Poitiers INSERM U1070, "Pharmacologie des Anti-Infectieux", Poitiers, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France
| | - E Bey
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urology and Andrology department, University Hospital of Nîmes, Nîmes, France
| | - C Le Goux
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Urologie Hôpital Privé Nord Parisien, Tassigy, Sarcelles, France
| | - F Saint
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Department of Urology and Transplantation, CHU Amiens-Picardie. EPROAD Laboratory EA 4669, Picardie Jules Verne University, France
| | - A Therby
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; CH Versailles, France
| | - J R Zahar
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Infection Control Unit, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Bobigny, France; University Sorbonne Paris Nord, Bobigny, France
| | - A Sotto
- CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France; Service de maladies infectieuses et tropicales, CHU de Nimes, Université de Nimes, France
| | - F Bruyere
- Faculté de médecine, Université de Tours, France; Service d'urologie, CHRU de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France
| | - L Grammatico-Guillon
- EpiDcliC, unité de santé publique, SIMEES, CHRU de Tours, France; Faculté de médecine, Université de Tours, France; CIAFU Comité d'infectiologie de l'Association Française d'Urologie, France.
| |
Collapse
|
15
|
Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Poussot B, Dupuis H, Hermieu N, Robin D, Pitout A, Beraud F, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B. Impact of the center volume activity on the results of artificial urinary sphincter in non-neurological male patients. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00506-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
16
|
Bentellis I, El-Akri M, Cornu J, Brierre T, Cousin T, Gaillard V, Poussot B, Dupuis H, Hermieu N, Robin D, Pitout A, Beraud F, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Hermieu J, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B. Prevalence and risk factors of artificial urinary sphincter revision in non-neurological male patients. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00507-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Mazouin C, Hubert J, Tricard T, Lecoanet P, Haudebert C, Bentellis I, Baron P, Hascoet J, Castes C, Tibi B, Pradere B, Bruyere F, Capon G, Manunta A, Saussine C, Peyronnet B. Robot-assisted cystectomy and ileal conduit for neurogenic bladder: Comparison of extracorporeal vs intracorporeal urinary diversion. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00422-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Rozet F, Mongiat-Artus P, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mathieu R, Ploussard G, Renard-Penna R, Brenot-Rossi I, Bruyere F, Cochet A, Crehange G, Cussenot O, Lebret T, Rebillard X, Soulié M, Brureau L, Méjean A. Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251]. Prog Urol 2021; 31:381-382. [PMID: 33941457 DOI: 10.1016/j.purol.2021.04.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- F Rozet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France; Institut mutualiste Montsouris, 42, boulevard Jourdan, 75014 Paris, France.
| | - P Mongiat-Artus
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - C Hennequin
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - J B Beauval
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - P Beuzeboc
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Cormier
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Fromont-Hankard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Mathieu
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Ploussard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - R Renard-Penna
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - I Brenot-Rossi
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - F Bruyere
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Cochet
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - G Crehange
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - O Cussenot
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - T Lebret
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - X Rebillard
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - M Soulié
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - L Brureau
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| | - A Méjean
- Comité de cancérologie de l'Association française d'urologie, groupe prostate, Maison de l'urologie, 11, rue Viète, 75017 Paris, France
| |
Collapse
|
19
|
Baron P, Khene Z, Ploussard G, Bruyere F, Gasmi A, Verhoest G, Perrot O, Roupret M, Bajeot A, Roumiguie M, Lannes F, Pignot G, Pradere B. Validation française d’un pentafecta pour une évaluation standardisée des résultats de la cystectomie totale laparoscopique robot-assistée pour cancer de vessie. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Benichou Y, Bernhard J, Bensalah K, Roupret M, Dariane C, Paparel P, Lebacle C, Bruyere F, Nouhaud F, Soulie M, Villers A, Lang H, Durand X, Bigot P, Long J, Champy C. Étude UROCCR 54 RURANPO : néphrectomie partielle sur rein unique : comparaison des voies ouverte et laparoscopique robot-assistée. Prog Urol 2020. [DOI: 10.1016/j.purol.2020.07.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Bruyere F, Vallee M, Kassab D, Bey E, Bouiller K, Pimpie R, Le Goux C, Malavaud S, Sotto A, Samy F. Recommandations de bonne pratique sur la prévention, le diagnostic et le traitement des infections sur matériel endo-urétéral de l’adulte. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Goujon A, Schoentgen N, Betari R, Thoulouzan M, Vanalderwerelt V, Oumakhlouf S, Brichart N, Pradere B, Roumiguie M, Rammal A, Bensalah K, Fournier G, Bruyere F, Grise P, Joulin V, Manunta A, Saint F, Huyghe E, Nouhaud F, Peyronnet B. Prognostic factors after adrenalectomy for adrenal metastasis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33197-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
23
|
Goujon A, Schoentgen N, Betari R, Gryn A, Vanalderwerelt V, Oumakhlouf S, Toulouzan M, Brichart N, Pradere B, Soulie M, Fournier G, Saint F, Bensalah K, Bruyere F, Joulin V, Nouhaud F, Huygue E, Manunta A, Peyronnet B. Laparoscopic adrenalectomy for adrenal metastasis: Comparison of the transperitoneal vs. retroperitoneal approaches. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33188-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
24
|
Peyronnet B, Vurture G, Vanalderwerelt V, Tariel F, Pradere B, Vincendeau S, Bruyere F, Mathieu R, Nitti V, Brucker B. Is there a role for surgical treatment in patients with Parkinson’s disease and benign prostatic obstruction? EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33037-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
25
|
Goujon A, Schoentgen N, Betari R, Thoulouzan M, Vanalderwerelt V, Oumakhlouf S, Brichart N, Pradere B, Roumiguie M, Rammal A, Soulie M, Fournier G, Bensalah K, Bruyere F, Grise P, Joulin V, Manunta A, Saint F, Huyghe E, Nouhaud FX, Peyronnet B. Prognostic factors after adrenalectomy for adrenal metastasis. Int Urol Nephrol 2020; 52:1869-1876. [PMID: 32419066 DOI: 10.1007/s11255-020-02496-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Accepted: 05/04/2020] [Indexed: 12/13/2022]
Abstract
PURPOSE Very few studies have sought prognostic factors after adrenalectomy for metastasis. The aim of this study was to assess prognostic factors for oncological outcomes after adrenalectomy for adrenal metastasis. METHODS All adrenalectomies for metastases performed in seven centers between 2006 and 2016 were included in a retrospective study. Recurrence-free survival (RFS) and cancer-specific survival (CSS) were estimated using the Kaplan-Meier method. Prognostic factors for CSS and RFS were sought by Cox regression analyses. RESULTS 106 patients were included. The primary tumors were mostly renal (47.7%) and pulmonary (32.3%). RFS and CSS estimated rates at 5 years were 20.7% and 63.7%, respectively. In univariate analysis, tumor size (HR 3.83; p = 0.04) and the metastasis timing (synchronous vs. metachronous; HR 0.47; p = 0.02) were associated with RFS. In multivariate analysis, tumor size (HR 8.28; p = 0.01) and metastasis timing (HR 18.60; p = 0.002) were significant factors for RFS. In univariate analysis, the renal origin of the primary tumor (HR 0.1; p < 0.001) and the disease-free interval (DFI; HR 0.12; p = 0.02) were associated with better CSS, positive surgical margins with poorer CSS (HR 3.4; p = 0.01). In multivariate analysis, the renal origin of the primary tumor vs. pulmonary (HR 0.13; p = 0.03) and vs. other origins (HR 0.10; p = 00.4) and the DFI (HR 0.01; p = 0.009) were prognostic factors for CSS. CONCLUSION In this study, tumor size and synchronous occurrence of the adrenal metastasis were associated with poorer RFS. Renal origin of the primary tumor and longer DFI were associated with better CSS. These prognostic factors might help for treatment decision in the management of adrenal metastasis.
Collapse
Affiliation(s)
- A Goujon
- Department of Urology, CHU Rennes, Rennes, France.
| | | | - R Betari
- Department of Urology, CHU Amiens, Amiens, France
| | - M Thoulouzan
- Department of Urology, CHU Toulouse, Toulouse, France
| | | | | | - N Brichart
- Department of Urology, CH Orleans, Orléans, France
| | - B Pradere
- Department of Urology, CHU Tours, Tours, France
| | - M Roumiguie
- Department of Urology, CHU Toulouse, Toulouse, France
| | - A Rammal
- Department of Urology, CH Orleans, Orléans, France
| | - M Soulie
- Department of Urology, CHU Toulouse, Toulouse, France
| | - G Fournier
- Department of Urology, CHU Brest, Brest, France
| | - K Bensalah
- Department of Urology, CHU Rennes, Rennes, France
| | - F Bruyere
- Department of Urology, CHU Tours, Tours, France
| | - P Grise
- Department of Urology, CHU Rouen, Rouen, France
| | - V Joulin
- Department of Urology, CHU Brest, Brest, France
| | - A Manunta
- Department of Urology, CHU Rennes, Rennes, France
| | - F Saint
- Department of Urology, CHU Amiens, Amiens, France
| | - E Huyghe
- Department of Urology, CHU Toulouse, Toulouse, France
| | - F-X Nouhaud
- Department of Urology, CHU Rouen, Rouen, France
| | - B Peyronnet
- Department of Urology, CHU Rennes, Rennes, France
| |
Collapse
|
26
|
Bruyere F, Goux L, Bey E, Cariou G, Cattoir V, Saint F, Sotto A, Vallée M. [Urinary tract infections in adults: Comparison of the French and the European guidelines]. Prog Urol 2020; 30:472-481. [PMID: 32418735 DOI: 10.1016/j.purol.2020.02.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2019] [Revised: 02/15/2020] [Accepted: 02/26/2020] [Indexed: 10/24/2022]
Abstract
INTRODUCTION Acute urinary tract infections (UTIs) in adult are now a major public health issue in terms of morbidity, mortality and in terms of costs for society. The latest French guidelines and the European Association of Urology guidelines differ in some points. The aim of this article is to compare the guidelines of these two societies in order to highlight their differences but also their common points in the management of UTIs. METHODS A comparative analysis of the latest French and European guidelines was carried out. The authors defined the following sub-sections: terminology, pyelonephritis, male UTIs, pregnancy urinary tract infections and cystitis. RESULTS AND CONCLUSION The guidelines of these two societies are not very different in terms of diagnostic and therapeutic management. The major differences are in the duration of antibiotic therapies, where French guidelines continue to recommend long term treatments where EAU sometimes recommends only 5 days of antibiotics, as in the case of simple acute pyelonephritis. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- F Bruyere
- Service d'urologie, CHRU de Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex, France; Service d'urologie, CHU de Bicêtre, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France.
| | - Le Goux
- Service d'urologie, CHU de Bicêtre, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France; Unité d'épidémiologie et hygiène hospitalière, CHU de Toulouse-Rangueil, 1, avenue Jean-Poulhès, 31059 Toulouse cedex 9, France
| | - E Bey
- Service d'urologie et de la transplantation rénale, CHU de Grenoble, boulevard de la Chantourne, 38700 La Tronche, France
| | - G Cariou
- Cabinet d'urologie, 18, rue Fabre-d'Eglantine, 75012 Paris, France
| | - V Cattoir
- Service de bactériologie-hygiène hospitalière, CHU de Rennes, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex 9, France
| | - F Saint
- Service d'urologie et de transplantation, CHU d'Amiens-Picardie, 80054 Amiens, France
| | - A Sotto
- Service des maladies infectieuses et tropicales, CHU de Nîmes, place du Pr-Debré, 30029 Nîmes cedex 09, France
| | - M Vallée
- Service d'urologie et de transplantations rénales, CHU La Milétrie, CHU de Poitiers, 2, rue de la Milétrie, 86021 Poitiers, France; Inserm U1070, UFR médecine-pharmacie, pharmacologie des anti-infectieux, pôle biologie santé, université de Poitiers, 1, rue Georges-Bonnet, bâtiment B36 TSA 51106, 86073 Poitiers cedex 9, France
| |
Collapse
|
27
|
Beauval J, Méjean A, Doumerc N, Roupret M, Paparel P, Villers A, Bruyere F, Lebacle C, Nouhaud F, De la Taille A, Rizk J, Lang H, Durand M, Dariane C, Charles T, Boissier R, Long J, Bensalah K, Bernard J. Résultats de la néphrectomie partielle RObot-assistée chez les patients oBESEs avec IMC >30 kg/m2 (étude UroCCR-43 : RoBèse). Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Boissier R, Bernhard J, Bigot P, Dariane C, Lang H, Doumerc N, Beauval J, Lebacle C, Bruyere F, Nouhaud F, Tillou X, Long J, Durand M, Charles T, Chevreau C, Oudard S, Albiges L, Ravaud A, Mejean A, Bensalah K. Intérêt du traitement adjuvant par antiangiogénique versus surveillance après néphrectomie pour tumeur rénale M0 avec thrombus de la veine rénale ou de la veine cave (étude UroCCR-56). Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
29
|
Michiels C, Bernhard J, Beauval J, Doumerc N, Roupret M, Vaessen C, Dariane C, Flamand V, Long JA, Paparel P, Baumert H, Bruyere F, Lang H, Salomon L, Guilloneau B, Descazeaud A, Lebret T, Arnaud M, Patard J, Bensalah K. Ropan : observatoire national sur la néphrectomie partielle robotisée. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Pradere B, Peyronnet B, Khene Z, Delporte G, Manach Q, Moulin M, Rizk J, Brichart N, Beauval J, Benoit T, Upret M, Bex A, Bruyere F, Bensalah K. Résultats oncologiques des tumeurs kystiques du rein comparées aux tumeurs solides : étude multicentrique. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Bruyere F, Laine P, St Jalmes G, Pradere B. Bétachrome : impact muqueux de la povidone iodée alcoolique indiquée dans la désinfection préopératoire. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
32
|
Khene Z, Peyronnet B, Bernhard J, Kocher N, Vaessen C, Doumerc N, Pradere B, Seisen T, Beauval J, Verhoest G, Mathieu R, Roumiguie M, De La Taille A, Bruyere F, Roupret M, Méjean A, Raman J, Bensalah K. Développement et validation d’un nomogramme pour prédire les complications majeures après néphrectomie partielle robot-assistée. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
33
|
Baron P, Pradere B, Ballereau C, Ruffion A, Vigneau A, Roupret M, Manach Q, Bruyere F. Prostatectomie radicale robot-assistée (RALP) post-chirurgie de l’adénome : étude rétrospective multicentrique. Prog Urol 2017. [DOI: 10.1016/j.purol.2017.07.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Bruyere F, Azzouzi A, Lavigne J, Bernard L, Droupy S, Game X, Ruffion A, Issartel B, Sotto A, Allaert F. Étude multicentrique, randomisée, en double aveugle contre placebo, évaluant l’efficacité et la tolérance d’une association de propolis et de canneberge (vaccinium macrocarpon) (DUAB ® ) dans la prévention de rechutes des infections urinaires récidivantes chez la femme. Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
35
|
Alimi Q, Seisen T, Bruyere F, Brichart N, Verhoest G, Graffeille V, Tondut L, Pradere B, Vanalderwerelt V, Rammal A, Vaessen C, Colin P, Roupret M, Bensalah K, Peyronnet B. Résultats périopératoires de la néphro-urétérectomie totale par voie laparoscopique pure versus robot assistée pour le traitement des tumeurs de la voie excrétrice urinaire supérieure. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
36
|
Fromont G, Figiel S, Maheo K, Pinault M, Blanchet P, Multigner L, Bruyere F, Mathieu R, Vincendeau S, Lebdai S, Azzouzi A, Perrouin-verbe M, Fournier G, Rigaud J, Charles T. Composition en acides gras du tissu adipeux périprostatique : association à l’agressivité tumorale et à l’origine ethno-géographique (réseau ReSCaP). Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Cornu JN, Amarenco G, Bruyere F, Chartier-Kastler E, Fatton B, Grise P, Haab F, Bourouina R. [Prevalence and initial management of overactive bladder in France: A cross-sectional study]. Prog Urol 2016; 26:415-24. [PMID: 27108102 DOI: 10.1016/j.purol.2016.04.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Revised: 03/31/2016] [Accepted: 04/01/2016] [Indexed: 01/16/2023]
Abstract
AIMS To determine the prevalence of overactive bladder (OAB) syndrome in France and gather data about initial patient trajectories in the healthcare system. METHODS A dedicated questionnaire (41 questions) has been sent to a 12,000 sample of people representative of the global population. The following data were investigated: social and demographic features, medical history, Urinary Symptom Profile questionnaire, bother, history of symptoms, care seeking and treatments received. Patient were considered having OAB in case if presenting at least two episodes of urgency per week, or being under treatment of OAB. OAB prevalence was the main outcome, and associated factors were characterized by univariate and multivariate analysis. RESULTS Based on 8842 available questionnaires, the global prevalence of OAB was estimated to be 14.4%. Prevalence was significantly higher in women, older age groups, as well as obesity, irritable bowel syndrome, urinary tract infections, enuresia, constipation, anxiety/depression, neurological diseases, sleep apnea syndrome, asthma, chronic obstructive pulmonary disease, diabetes and hypertension. Only 34.6% of patients with OAB had visited a health practitioner for this problem. General practitioners were most frequently implicated in patient primary care and evaluation. Seventy-two percent of patients with OAB had had additional investigations (mostly a urine culture) and only 6% of patients had to complete a bladder diary. The most frequent treatment option was oral antimuscarinics. Physical therapy and rehabilitation have been prescribed in 26% of cases, as well as dietary advice. CONCLUSIONS OAB is a frequent syndrome. Its prevalence increases with age, and OAB frequently concern elderly frail people with many other associated diseases. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- J-N Cornu
- Chirurgie urologique, université de Rouen, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France.
| | - G Amarenco
- Sorbonne universités, UPMC université Paris 06, GRC 01, GREEN, Group of Clinical Research in Neuro-Urology, 75005 Paris, France; Service de neuro-urologie et d'explorations périnéales, hôpital Tenon, AP-HP, 75020 Paris, France
| | - F Bruyere
- Chirurgie urologique, CHRU Le Bretonneau, 2, boulevard Tonnelé, 37000 Tours, France
| | - E Chartier-Kastler
- Faculté de médecine Pierre-et-Marie-Curie, Paris 6, hôpital universitaire Pitié-Salpetrière, AP-HP, 83, boulevard de l'Hôpital, 75013 Paris, France
| | - B Fatton
- Gynécologie/obstétrique, CHU Caremeau, 4, rue Professeur-Robert-Debré, 30029 Nîmes, France
| | - P Grise
- Chirurgie urologique, université de Rouen, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - F Haab
- Centre urologie Paris Opéra, 75009 Paris, France
| | - R Bourouina
- Astellas Pharma, 26, quai Michelet, CS 90067, 92309 Levallois-Perret cedex, France
| |
Collapse
|
38
|
Leonard G, Pradere B, Hibon G, Peyronnet B, Bruyere F. Étude prospective randomisée sur l’intérêt du sondage vésical en système clos au bloc opératoire : résultats préliminaires. Prog Urol 2015; 25:775-6. [DOI: 10.1016/j.purol.2015.08.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
39
|
Encatassamy F, Valentin A, Buchler M, Bruyere F. Impact sur les greffons de la colonisation du liquide de conservation. Prog Urol 2015; 25:763-4. [DOI: 10.1016/j.purol.2015.08.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
40
|
Cossin S, Malavaud S, Jarno P, Giard M, L'Hériteau F, Simon L, Bieler L, Molinier L, Marcheix B, Venier AG, Simon L, Ali-Brandmeyer O, Neels C, Jarno P, Aupée M, Perennec M, Astagneau P, L'Hériteau F, Daniel F, Campion C, Giard M, Bernet C, Caillat-Vallet E, Venier AG, Bervas C, Reyreaud E, Baillet P, Costa Y, Jost JL, Merle V, Merlo L, Seguier JC, Malavaud S, Bruyere F, Thiolet JM, Barquin-Guichard S. Surgical site infection after valvular or coronary artery bypass surgery: 2008–2011 French SSI national ISO-RAISIN surveillance. J Hosp Infect 2015; 91:225-30. [DOI: 10.1016/j.jhin.2015.07.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Accepted: 07/16/2015] [Indexed: 11/17/2022]
|
41
|
May A, Bergot C, Boutin J, Branchereau J, Karam G, Bruyere F. Existe-t-il une différence de résultats entre la laparoscopie « hand assisted » et la laparoscopie robot-assistée pour néphrectomie donneur vivant ? Prog Urol 2015; 25:724. [DOI: 10.1016/j.purol.2015.08.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Monleon L, Bodin T, Bruyere F. Évaluation de l’efficacité de la photovaporisation prostatique par laser Greenlight 180W sur les volumes prostatiques supérieurs à 120 cc. Prog Urol 2015; 25:730. [DOI: 10.1016/j.purol.2015.08.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Hibon G, Leonard G, Franceschi A, Bruyere F. Étude comparative prospective multicentrique entre photovaporisation classique et vaporisation anatomique par laser Greenlight pour les adénomes prostatiques de gros volume. Prog Urol 2015; 25:728-9. [DOI: 10.1016/j.purol.2015.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
44
|
Fromont G, Vasseur C, Guibon R, Bruyere F, Haillot O. Marqueurs de la transition épithélio-mésenchymateuse et marques épigénétiques associées dans le développement et la progression du cancer de la prostate. Prog Urol 2015; 25:734-5. [DOI: 10.1016/j.purol.2015.08.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
45
|
Thomas JA, Tubaro A, Barber N, d' Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink J, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi N, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Bachmann A. PD5-10 TRANSURETHRAL RESECTION OF THE PROSTATE (GL-XPS OR TURP) DOES NOT RESULT IN SIGNIFICANT IMPAIRMENT OF ERECTILE FUNCTION. J Urol 2015. [DOI: 10.1016/j.juro.2015.02.309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Le Brun C, Robert S, Bruyere F, Lanotte P. [Emerging uropathogens: Point for urologists and biologists]. Prog Urol 2015; 25:363-9. [PMID: 25726694 DOI: 10.1016/j.purol.2015.01.021] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2014] [Revised: 01/24/2015] [Accepted: 01/30/2015] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Technological advances during the last years in bacterial identification by molecular biology and mass spectrometry, or Matrix Assisted Laser Desorption Ionisation-Time of Flight (MALDI-TOF) have allowed identifying new bacteria involved in urinary tract infections. The purpose of this review is to familiarize clinicians with these bacteria so that they can look at a particular target population and help biologists to suspect and identify them. METHOD A bibliographic research was performed using the Medline database concerning the keywords Aerococcus, Actinobaculum, Alloscardovia, Trueperella. RESULTS If Aerococcus sp. is now well known, Actinobaculum sp., Alloscardovia sp. and Trueperella sp. remain rarely isolated and unknown from clinicians. Importance of these germs could be underestimated because of the identifying and isolation difficulties which existed beforehand. They are particularly found in a population of elderly people with underlying conditions or urological risk factors of urinary tract infection. Actinobaculum schaalii is also found more frequently in young children. CONCLUSION Aerococcus sp. et A. schaalii are true uropathogens not to be underestimated. Further studies are still needed to confirm the specific involvement of Trueperella and Alloscardovia in urinary diseases.
Collapse
Affiliation(s)
- C Le Brun
- Laboratoire de bactériologie-virologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnelé, 37044 Tours cedex, France.
| | - S Robert
- Laboratoire de bactériologie-virologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnelé, 37044 Tours cedex, France
| | - F Bruyere
- Service d'urologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnelé, 37044 Tours cedex, France
| | - P Lanotte
- Laboratoire de bactériologie-virologie, hôpital Bretonneau, CHRU de Tours, 2, boulevard Tonnelé, 37044 Tours cedex, France
| |
Collapse
|
47
|
Hupertan V, Rouprêt M, Bruyere F, Misrai V. Traitement de l’adénome de la prostate au laser Greenlight XPS : proposition d’un outil de prédiction (nomogramme) préopératoire des résultats fonctionnels attendus. Prog Urol 2014; 24:791-2. [DOI: 10.1016/j.purol.2014.08.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Fromont G, Sebag M, Rio P, Bruyere F, Haillot O, Faivre d’Arcier B, Brichart N. Étude des effets des acides gras insaturés et du tissu adipeux péri-prostatique sur des cellules tumorales de prostate. Prog Urol 2014; 24:784-5. [DOI: 10.1016/j.purol.2014.08.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
49
|
Bruyere F, Ruimy J, Elfassi R, Boyer O, Fabrice A, De Honnaville C. Analyse des facteurs prédictifs de récidive des prostatites aiguës bactériennes communautaires au sein d’une cohorte prospective de 158 malades pris en charge en ambulatoire dans un réseau de soin. Prog Urol 2014; 24:839. [DOI: 10.1016/j.purol.2014.08.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Peyronnet B, Pradere B, Brichart N, Bodin T, Bertrand P, Bruyère F, Atassi A, Benmeziani R, Bodin T, Breque M, Brichart N, Bron J, Bruyere F, Cloche P, Corbel L, Cormier L, Cuvelier G, Delporte G, Fennouri M, Ferhi K, Fournier G, Gabbay G, Hurtes X, Laplace B, Le Gal S, Lecouteux A, Lesur G, Lokmane M, Mathieu R, Metois P, Miaadi N, Misrai V, Moreau J, Mouly P, Muyshondt C, Obringer L, Perrouin-Verbe M, Peyronnet B, Pradere B, Prezelin Y, Rigaud P, Salin A, Tabchouri N, Tanchoux C, Theveniaud P, Thoulouzan M, Thuillier C, Verhoest G. Complications Associated With Photoselective Vaporization of the Prostate: Categorization by a Panel of GreenLight Users According to Clavien Score and Report of a Single-center Experience. Urology 2014; 84:657-64. [DOI: 10.1016/j.urology.2014.05.028] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2014] [Revised: 05/21/2014] [Accepted: 05/23/2014] [Indexed: 11/16/2022]
|